Αυστρία - Γερμανικά - AGES (Agentur für Gesundheit und Ernährungssicherheit)

sandoz gmbh - cefazolin natrium - cefazolin

Αυστρία - Γερμανικά - AGES (Agentur für Gesundheit und Ernährungssicherheit)

sandoz gmbh - cefazolin natrium - cefazolin

Αυστρία - Γερμανικά - AGES (Agentur für Gesundheit und Ernährungssicherheit)

sandoz gmbh - cefazolin natrium - cefazolin

Γερμανία - Γερμανικά - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

organon healthcare gmbh (1007295) - mometason-17-(2-furoat) 1 h<2>o - nasenspray, suspension - teil 1 - nasenspray, suspension; mometason-17-(2-furoat) 1 h<2>o (29158) 0,052 milligramm

Ευρωπαϊκή Ένωση - Γερμανικά - EMA (European Medicines Agency)

novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - immunsuppressiva - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriasis-arthritiscosentyx, allein oder in kombination mit methotrexat (mtx), ist indiziert zur behandlung der aktiven psoriasis-arthritis bei erwachsenen patienten, wenn die antwort zur vorherigen krankheitsmodifizierenden anti-rheumatischen droge (dmard) therapie unzureichend. axiale spondyloarthritiden (axspa)ankylosierende spondylitis (as, röntgenologische axiale spondyloarthritiden)cosentyx ist indiziert für die behandlung des aktiven morbus bechterew bei erwachsenen, die geantwortet haben, die unzureichend auf eine konventionelle therapie. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.

Ευρωπαϊκή Ένωση - Γερμανικά - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - asthma - medikamente für obstruktive atemwegserkrankungen, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Ευρωπαϊκή Ένωση - Γερμανικά - EMA (European Medicines Agency)

novartis europharm limited - crizanlizumab - anämie, sichelzellen - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.

Γερμανία - Γερμανικά - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

koanaa healthcare spain s.l. (1010198) - fingolimodhydrochlorid - hartkapsel - 0,5 mg - teil 1 - hartkapsel; fingolimodhydrochlorid (30117) 0,56 milligramm

Γερμανία - Γερμανικά - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

betapharm arzneimittel gmbh (3364323) - pregabalin - hartkapsel - 100 mg - pregabalin (29682) 100 milligramm

Γερμανία - Γερμανικά - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

betapharm arzneimittel gmbh (3364323) - pregabalin - hartkapsel - 25 mg - pregabalin (29682) 25 milligramm